Aller au contenu principal
Retour à l'annuaire
RI
Rhumatologue

Docteur RACHIDA INAOUI-ROZE

📍 Paris 15e Arrondissement (75)MixteRPPS 10003747721

✨ Profil synthétique

IA · 04/05/2026

Le Docteur RACHIDA INAOUI-ROZE est rhumatologue à Paris. Ses publications sur PubMed couvrent divers aspects de la rhumatologie, notamment les revues générales, les études de cas, les méta-analyses et l'épidémiologie. Ses recherches portent également sur les biomarqueurs et les traitements par les csDMARDs.

Expertises présumées

  • Polyarthrite rhumatoïde
  • Spondylarthropathies
  • Lupus érythémateux systémique
  • Arthrite psoriasique
  • Biomarqueurs en rhumatologie
  • Thérapeutique par csDMARDs
  • Épidémiologie des maladies rhumatismales

Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.

Diplômes

🎓 DES & spécialité ordinale

  • DES Rhumatologie
  • Rhumatologie (SM)

🎓 Diplômes

  • DE Docteur en médecine

Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.

Localisation

Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.

Lieux de consultation

  • CDS MEDICAL MGEN

    178 Rue DE VAUGIRARD, 75738 Paris 15e Arrondissement

    ☎ 0144492828Hospitalier

  • CABINET DU DR RACHIDA INAOUI-ROZE

    35-37 — 35 RUE BROCA, 75005 Paris

    Libéral
    Plaque Rue Broca - Paris V (FR75) - 2026-04-05 - 140 mPlaque Rue Broca - Paris V (FR75) - 2026-04-05 - 240 mRue Lyonnais - Paris V (FR75) - 2026-04-05 - 141 mRue Broca - Paris V (FR75) - 2026-04-05 - 141 m
    © OpenStreetMap · Photos Wikimedia Commons (CC)
    📷 Street View ↗🗺️ Maps ↗OSM ↗

  • GHU APHP SUN SITE PITIE SALPETRIERE

    47-83 — 47 Boulevard DE L HOPITAL, 75651 Paris 13e Arrondissement

    ☎ 0142160000Hospitalier

Tarifs & secteur de conventionnement

Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).

📊 Comprendre le remboursement

Prendre rendez-vous & contact

🗓 Trouver sur Doctolib📇 Ajouter à mes contacts

Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).

Top publications · les plus citées

  • 1
    SARS-CoV-2 genomic surveillance in wastewater as a model for monitoring evolution of endemic viruses

    Nature communications · 2023

    📚 44 citations🎯 RCR 5.12Top 7% NIH🔓 Open Access📄 PDF gratuit ↗
    Lire l'abstract Crossref ↓

    AbstractAs global SARS-CoV-2 burden and testing frequency have decreased, wastewater surveillance has emerged as a key tool to support clinical surveillance efforts. The aims of this study were to identify and characterize SARS-CoV-2 variants in wastewater samples collected from urban centers across South Africa. Here we show that wastewater sequencing analyses are temporally concordant with clinical genomic surveillance and reveal the presence of multiple lineages not detected by clinical surveillance. We show that wastewater genomics can support SARS-CoV-2 epidemiological investigations by reliably recovering the prevalence of local circulating variants, even when clinical samples are not available. Further, we find that analysis of mutations observed in wastewater can provide a signal of upcoming lineage transitions. Our study demonstrates the utility of wastewater genomics to monitor evolution and spread of endemic viruses.

  • 2
    Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys

    Rheumatology (Oxford, England) · 2023

    📚 18 citations🎯 RCR 2.15Top 25% NIH🔓 Open Access📄 PDF gratuit ↗
    Lire l'abstract Crossref ↓

    Abstract Objective COVID-19 vaccines have a favorable safety profile in patients with autoimmune rheumatic diseases (AIRDs) such as idiopathic inflammatory myopathies (IIMs); however, hesitancy continues to persist among these patients. Therefore, we studied the prevalence, predictors and reasons for hesitancy in patients with IIMs, other AIRDs, non-rheumatic autoimmune diseases (nrAIDs) and healthy controls (HCs), using data from the two international COVID-19 Vaccination in Autoimmune Diseases (COVAD) e-surveys. Methods The first and second COVAD patient self-reported e-surveys were circulated from March to December 2021, and February to June 2022 (ongoing). We collected data on demographics, comorbidities, COVID-19 infection and vaccination history, reasons for hesitancy, and patient reported outcomes. Predictors of hesitancy were analysed using regression models in different groups. Results We analysed data from 18 882 (COVAD-1) and 7666 (COVAD-2) respondents. Reassuringly, hesitancy decreased from 2021 (16.5%) to 2022 (5.1%) (OR: 0.26; 95% CI: 0.24, 0.30, P < 0.001). However, concerns/fear over long-term safety had increased (OR: 3.6; 95% CI: 2.9, 4.6, P < 0.01). We noted with concern greater skepticism over vaccine science among patients with IIMs than AIRDs (OR: 1.8; 95% CI: 1.08, 3.2, P = 0.023) and HCs (OR: 4; 95% CI: 1.9, 8.1, P < 0.001), as well as more long-term safety concerns/fear (IIMs vs AIRDs – OR: 1.9; 95% CI: 1.2, 2.9, P = 0.001; IIMs vs HCs – OR: 5.4 95% CI: 3, 9.6, P < 0.001). Caucasians [OR 4.2 (1.7–10.3)] were likely to be more hesitant, while those with better PROMIS physical health score were less hesitant [OR 0.9 (0.8–0.97)]. Conclusion Vaccine hesitancy has decreased from 2021 to 2022, long-term safety concerns remain among patients with IIMs, particularly in Caucasians and those with poor physical function.

  • 3
    The role of wastewater-based epidemiology for SARS-CoV-2 in developing countries: Cumulative evidence from South Africa supports sentinel site surveillance to guide public health decision-making

    The Science of the total environment · 2023

    📚 13 citations🎯 RCR 1.59🔓 Open Access📄 PDF gratuit ↗

Publications scientifiques (50) — classées par pathologie

Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).

Transversal27

▼

Revue générale8

▼

Case report / série6

▼

Revue / méta-analyse3

▼

Épidémiologie & registres2

▼

Biomarqueurs / Auto-Ac1

▼

csDMARDs1

▼

Économie santé1

▼

Essai clinique1

▼

Ostéoporose1

▼

Pédiatrie1

▼

Santé mentale / fatigue1

▼

SAPL1

▼

Sclérodermie1

▼

Vascularites des gros vaisseaux1

▼

Vraie vie / RWE1

▼

Partager cette fiche

in LinkedIn🟢 WhatsApp✉ Email

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.